SCHEMBL17875939

SCHEMBL17875939

O=S1(=O)Cc2cc(-c3ccc4oc5ccccc5c4c3)ccc2-c2cc(-c3cccc4c3oc3ccccc34)ccc2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.46
PRKDC P78527 7/20 0.40
GGPS1 O95749 1/20 0.39
PTGES2 Q9H7Z7 1/20 0.36
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ATM Q13315 1/20 0.34
PRMT5 O14744 1/20 0.34
WDR77 Q9BQA1 1/20 0.34
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875924 1.00 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2HSP90AA1
SCHEMBL17875987 0.96 ALOX5 (0.50) ALOX5PRKDCGGPS1PTGES2HSP90AA1
SCHEMBL17875928 0.94 ALOX5 (0.51) ALOX5PRKDCGGPS1PTGES2MEN1
SCHEMBL17875921 0.94 PRKDC (0.47) ALOX5PRKDCGGPS1PTGES2KDM4E
SCHEMBL17875932 0.94 PRKDC (0.47) ALOX5PRKDCGGPS1PTGES2KDM4E
SCHEMBL17875930 0.92 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2ATM
SCHEMBL17875948 0.92 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2ATM
SCHEMBL17875944 0.91 MEN1 (0.41) HSP90AA1HSP90AB1KDM4EMEN1NPC1
SCHEMBL17875955 0.91 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2ATM
SCHEMBL17875931 0.91 ALOX5 (0.46) ALOX5PRKDCGGPS1PTGES2ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 ALOX5 3059/4885PRKDC 4858/4885GGPS1 1622/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALOX5 3059/4885PRKDC 4858/4885GGPS1 1622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.